Myalgic Encephalomyelitis (M.E.) According to the International Consensus Criteria (ICC 2011)

Purpose

This page provides an overview of Myalgic Encephalomyelitis (M.E.) as defined by the International Consensus Criteria (ICC 2011). It highlights the multi-system nature of the disease, with a focus on cardiovascular involvement, symptom patterns, and principles of management.

Key Points

1. M.E. as a Multi-System Disease

  • M.E. is a complex neuroimmune disease, not simply fatigue
  • Affects multiple body systems, including:

2. Cardiovascular and Circulatory Dysfunction

Common cardiovascular issues in M.E. include:

  • Orthostatic intolerance
    • Difficulty maintaining blood flow when upright
    • Symptoms: dizziness, palpitations, faintness
  • Reduced blood volume and poor circulation
    • Leads to reduced oxygen delivery to tissues and brain
  • Autonomic nervous system dysfunction
    • Impairs regulation of heart rate and blood pressure
  • Abnormal cardiac function (in some patients)
    • Reduced cardiac output
    • Impaired heart filling

3. Impact of Post-Exertional Neuroimmune Exhaustion (PENE)

  • Even minor activity can cause significant worsening of symptoms
  • PENE places additional strain on the cardiovascular system
  • Symptoms may intensify after exertion

4. Additional Cardiovascular Findings (Subset of Patients)

  • Some research suggests:
    • Myocardial (heart muscle) inflammation
    • Endothelial dysfunction (blood vessel regulation issues)
    • Cardiomyopathy-like changes
  • These findings are not present in all patients

5. Severe Disease Impact

  • In severe cases, individuals may:
    • Be unable to tolerate upright posture
    • Become bedbound
    • Experience extreme hypersensitivity
  • The body may struggle to meet normal circulatory demands

6. Important Clinical Context

  • Cardiovascular symptoms should not be assumed to be anxiety or deconditioning
  • Not all patients develop structural heart disease
  • Proper medical evaluation is important when symptoms occur

7. Variability Between Patients

  • Not all individuals experience the same degree of cardiovascular involvement
  • Circulation and heart-related findings vary across patients
  • Severity influences symptom expression

8. Management Approaches

  • Pacing and energy management
    • Staying within energy limits to prevent crashes
  • Environmental adjustments
    • Reducing heat and sensory overload
  • Volume support
    • Increasing fluid and salt intake where appropriate
  • Symptom-based treatment
    • Medications to support blood pressure and heart rate when needed

Target Audience

This information is intended for:

  • People living with M.E.
  • Carers and family members
  • Healthcare professionals
  • Researchers and advocates

Overall Outcome

This page highlights that M.E., as defined by the ICC 2011, is a serious multi-system illness with significant cardiovascular involvement in many patients. It emphasises the importance of recognising these symptoms as part of the disease process rather than misattributing them.

Understanding this helps:

  • Improve clinical recognition of cardiovascular symptoms
  • Support safer and more appropriate management
  • Prevent misdiagnosis or dismissal
  • Reinforce the complex biological nature of M.E.

Key Summary Statement

M.E. is a multi-system neuroimmune disease that often involves significant cardiovascular and autonomic dysfunction, requiring careful recognition, pacing, and symptom management rather than dismissal as fatigue or anxiety.

Download
File Type: pdf
File Size: 33 KB
Categories: Medical Papers
Author: Group Papers / Other
rank_math_internal_links_processed: 1
rank_math_seo_score: 6
rank_math_contentai_score: a:5:{s:8:"keywords";s:5:"74.51";s:9:"wordCount";s:1:"0";s:9:"linkCount";s:1:"0";s:12:"headingCount";s:1:"0";s:10:"mediaCount";s:1:"0";}
rank_math_primary_doc_categories: 0